

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1419, 2004-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Topiramate effective in migraine prophylaxis
Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. :


Topiramate for migraine prophylaxis
Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. :




Extended-release (XR) venlafaxine appears effective in the prevention of migraine and CTTH
Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. :


ACE inhibitor therapy appears to be cost effective in HF
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. :